Display options
Share it on

Virology. 1983 Nov;131(1):230-41. doi: 10.1016/0042-6822(83)90548-2.

A study of the glycoproteins of Autographa californica nuclear polyhedrosis virus (AcNPV).

Virology

B Stiles, H A Wood

Affiliations

  1. Boyce Thompson Institute at Cornell University, Tower Road, Ithaca, New York 14853, USA.

PMID: 18639173 PMCID: PMC7131021 DOI: 10.1016/0042-6822(83)90548-2

Abstract

Pulse labeling with tritiated mannose was used to follow the time course of Autographa californica nuclear polyhedrosis virus (AcNPV) glycoprotein synthesis in Spodoptera frugiperda IPLB-21 cells. Nine viral-induced intracellular glycoproteins were first detected from as early as 2 hr postinoculation (67K, early phase) to as late as 14 hr (36K and 19K glycoproteins, intermediate phase). Glycosylation of these proteins was observed to continue to the end of the experiment (28 hr postinoculation). Seven of these intracellular glycoproteins could also be detected in infected Trichoplusia ni TN-368 cells 24 hr postinoculation. When the glycosylation inhibitor tunicamycin was present (from 0 hr postinoculation) there was no detectable glycosylation of any of these viral-induced glycoproteins. Metabolic labeling of the nonoccluded virus budded from IPLB-21 and TN-368 with tritiated mannose or N-acetylglucosamine identified 11 structural glycoproteins, 8 of which were identical in both virus preparations. All of these structural glycoproteins were sensitive to the inhibitory action of tunicamycin. A single 42K structural glycoprotein was detected (with acetylglucosamine only) in the occluded form of AcNPV. Glycosylation of this structural protein appeared to be insensitive to tunicamycin. Lactoperoxidase-catalyzed radioiodination was used to determine which of the virus structural glycoproteins are exposed on the virion surface.

References

  1. J Supramol Struct. 1977;7(3-4):371-9 - PubMed
  2. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  3. Virology. 1981 May;111(1):56-72 - PubMed
  4. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6430-4 - PubMed
  5. Virology. 1980 Jun;103(2):446-64 - PubMed
  6. Arch Virol. 1980;64(2):119-26 - PubMed
  7. Methods Enzymol. 1981;72:296-303 - PubMed
  8. Virology. 1980 Apr 15;102(1):21-7 - PubMed
  9. Appl Environ Microbiol. 1983 Aug;46(2):297-303 - PubMed
  10. Virology. 1980 Dec;107(2):313-9 - PubMed
  11. J Gen Virol. 1982 Dec;63(2):343-9 - PubMed
  12. Annu Rev Biochem. 1981;50:555-83 - PubMed
  13. Virology. 1978 Feb;84(2):390-402 - PubMed
  14. Virology. 1981 Dec;115(2):334-44 - PubMed
  15. Nature. 1970 May 2;226(5244):466-7 - PubMed
  16. Cell. 1982 Jan;28(1):5-6 - PubMed
  17. J Virol. 1979 Nov;32(2):412-9 - PubMed
  18. J Virol. 1982 Feb;41(2):367-75 - PubMed
  19. J Cell Biol. 1972 Nov;55(2):390-405 - PubMed
  20. J Gen Virol. 1980 Sep;50(1):1-21 - PubMed
  21. J Virol. 1983 Apr;46(1):137-42 - PubMed
  22. J Gen Virol. 1981 Nov;57(Pt 1):43-52 - PubMed
  23. Virology. 1980 Jun;103(2):392-9 - PubMed
  24. CRC Crit Rev Biochem. 1979;6(2):165-217 - PubMed
  25. Virology. 1979 Dec;99(2):386-98 - PubMed
  26. Virology. 1981 Nov;115(1):149-60 - PubMed
  27. Biochim Biophys Acta. 1981 Feb 6;640(3):672-86 - PubMed
  28. J Mol Biol. 1981 Dec 25;153(4):993-1010 - PubMed
  29. Virology. 1981 Feb;109(1):25-34 - PubMed
  30. Virology. 1970 Oct;42(2):473-81 - PubMed

Publication Types